Tema Oncology ETF (CANC)

Assets	$69.59M
Expense Ratio	0.75%
PE Ratio	20.39
Shares Out	2.85M
Dividend (ttm)	$0.73
Dividend Yield	2.88%
Ex-Dividend Date	Dec 11, 2024
Payout Ratio	60.14%
1-Year Return	-10.02%

Volume	4,726
Open	25.30
Previous Close	25.31
Day's Range	24.74 - 25.30
52-Week Low	20.10
52-Week High	30.11
Beta	n/a
Holdings	53
Inception Date	Aug 15, 2023

About CANC

Fund Home Page

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NASDAQ
• Ticker Symbol: CANC
• ETF Provider: Tema

Top 10 Holdings

44.00% of assets

Name	Symbol	Weight
Revolution Medicines, Inc.	RVMD	5.30%
Roche Holding AG	RHHBY	5.23%
Eli Lilly and Company	LLY	5.18%
BridgeBio Pharma, Inc.	BBIO	4.60%
Novartis AG	NOVN	4.33%
AstraZeneca PLC	AZN	4.17%
Exelixis, Inc.	EXEL	4.06%
Merus N.V.	MRUS	3.79%
Genmab A/S	GMAB	3.78%
Bristol-Myers Squibb Company	BMY	3.55%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 11, 2024	$0.72827	Dec 12, 2024
Dec 13, 2023	$0.14911	Dec 15, 2023